The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer's disease: A positron emission tomography study in rats

被引:0
|
作者
Jae-Hyung Park
Jeong-Ho Hong
Sang-Woo Lee
Hyun Dong Ji
Jung-Ah Jung
Kyung-Wha Yoon
Jung-In Lee
Kyoung Sook Won
Bong-Il Song
Hae Won Kim
机构
[1] Department of Physiology,
[2] School of Medicine,undefined
[3] Keimyung University,undefined
[4] Department of Neurology,undefined
[5] School of Medicine,undefined
[6] Keimyung University,undefined
[7] Department of Nuclear Medicine,undefined
[8] School of Medicine,undefined
[9] Kyungpook National University,undefined
[10] Department of Nuclear Medicine,undefined
[11] School of Medicine,undefined
[12] Keimyung University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cerebrovascular disease is a potential risk factor for Alzheimer's disease (AD). Although acute cerebral hypoperfusion causes neuronal necrosis and infarction, chronic cerebral hypoperfusion induces apoptosis in neurons, but its effects on the cognitive impairment are not clear. The purpose of this study was to evaluate the effects of chronic cerebral hypoperfusion on AD pathology and cerebral glucose metabolism. A model of chronic cerebral hypoperfusion was established by ligating the common carotid arteries bilaterally in adult male rats (CAL group). Sham-operated rats underwent the same procedures without artery ligation (control group). At 12 weeks after ligation, expression levels of amyloid-β (Aβ) and hyperphosphorylated tau (p-tau), as well as the regional cerebral glucose metabolism, were evaluated using Western blots and positron emission tomography with fluorine-18 fluorodeoxyglucose, respectively. The expression levels of Aβ in the frontal cortex and hippocampus and of p-tau in the temporal cortex were significantly higher in the CAL group than those in the control group. The cerebral glucose metabolism of the amygdala, entorhinal cortex, and hippocampus was significantly decreased in the CAL group compared to that in the control. These results suggest that chronic cerebral hypoperfusion can induce AD pathology and may play a significant role in AD development.
引用
收藏
相关论文
共 50 条
  • [21] Amyloid load and cerebral atrophy in Alzheimer's disease:: An 11C-PIB positron emission tomography study
    Archer, Hilary A.
    Edison, Paul
    Brooks, David J.
    Barnes, Jo
    Frost, Chris
    Yeatman, Toni
    Fox, Nick C.
    Rossor, Martin N.
    ANNALS OF NEUROLOGY, 2006, 60 (01) : 145 - 147
  • [22] Neuronal substrates for semantic memory: A positron emission tomography study in Alzheimer's disease
    Hirono, N
    Mori, E
    Ishii, K
    Imamura, T
    Tanimukai, S
    Kazui, H
    Hashimoto, M
    Takatsuki, Y
    Kitagaki, H
    Sasaki, M
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (01) : 15 - 21
  • [23] Positron emission tomography and single photon emission computed tomography imaging in Alzheimer's disease
    Mentis, MJ
    NEUROLOGIST, 2000, 6 (01) : 28 - 43
  • [24] The role of positron emission tomography in the diagnosis of Alzheimer's disease - Response
    Gill, SS
    Rochon, PA
    Guttman, M
    Laupacis, A
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (03) : 468 - 469
  • [25] Protective effects of edaravone on white matter pathology in a novel mouse model of Alzheimer's disease with chronic cerebral hypoperfusion
    Feng, Tian
    Yamashita, Toru
    Sasaki, Ryo
    Tadokoro, Koh
    Matsumoto, Namiko
    Hishikawa, Nozomi
    Abe, Koji
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (06): : 1437 - 1448
  • [26] Machine learning in the positron emission tomography imaging of Alzheimer's disease
    Ayubcha, Cyrus
    Singh, Shashi B.
    Patel, Krishna H.
    Rahmim, Arman
    Hasan, Jareed
    Liu, Litian
    Werner, Thomas
    Alavi, Abass
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (09) : 751 - 766
  • [27] The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
    Jagust, William J.
    Bandy, Dan
    Chen, Kewei
    Foster, Norman L.
    Landau, Susan M.
    Mathis, Chester A.
    Price, Julie C.
    Reiman, Eric M.
    Skovronsky, Daniel
    Koeppe, Robert A.
    ALZHEIMERS & DEMENTIA, 2010, 6 (03) : 221 - 229
  • [28] The role of positron emission tomography imaging in understanding Alzheimer's disease
    Barthel, Henryk
    Seibyl, John
    Sabri, Osama
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (04) : 395 - 406
  • [29] Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia
    Mielke, R
    Heiss, WD
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1998, (53): : 237 - 250
  • [30] Positron emission tomography in Alzheimer's disease: early prediction and differentiation
    Mistur, Rachel
    Mosconi, Lisa
    De Santi, Susan
    Li, Yi
    Tsui, Wai
    de Leon, Mony
    FUTURE NEUROLOGY, 2009, 4 (01) : 23 - 38